Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The concept of **blood glucose stabilization via slow carbohydrate absorption** describes dietary or pharmacological interventions that reduce the rate at which ingested carbohydrates are digested into glucose and absorbed into the bloodstream[2][3]. This can be achieved through foods rich in fiber and slowly digestible starch (SDS), enzyme inhibitors like acarbose that block carbohydrate-digesting enzymes in the gut, or foods with a low glycemic index. Such interventions aim to blunt the postprandial blood glucose spike and reduce demand for insulin, thus lowering the risk or aiding control of metabolic diseases like type 2 diabetes and obesity. There is no single molecule, receptor, or protein target—rather, the strategy exploits physiological processes involving many enzymes, transporters, and hormones[2][5][3].
Inhibition of carbohydrate-digesting enzymes (e.g., alpha-glucosidase inhibition) - Delayed gastric emptying - Physical slow-release effects from food matrix (fiber, resistant starch)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Blood glucose stabilization via slow carbohydrate absorption.